Revance Therapeutics, Inc. (RVNC) financial statements (2021 and earlier)

Company profile

Business Address 1222 DEMONBREUN STREET
NASHVILLE, TN 37203
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:437290176283186252171
Cash and cash equivalents3341717328364202171
Short-term investments103119103 12251 
Other undisclosed cash, cash equivalents, and short-term investments(0)(0)(0)0(0)  
Restricted cash and investments     00
Receivables2 270000
Inventory, net of allowances, customer advances and progress billings6      
Inventory6      
Prepaid expense   2111
Other current assets   0000
Other undisclosed current assets675(0)6  
Total current assets:450297208285193254173
Noncurrent Assets
Operating lease, right-of-use asset3027
Property, plant and equipment1715149112019
Long-term investments and receivables     2 
Long-term investments     2 
Intangible assets, net (including goodwill), including:71      
Goodwill147      
Intangible assets, net (excluding goodwill)71      
Other undisclosed intangible assets, net (including goodwill)(147)      
Prepaid expense      0
Restricted cash and investments3111100
Other noncurrent assets12311 0
Other undisclosed noncurrent assets147     (0)
Total noncurrent assets:270441810122220
TOTAL ASSETS:720340226296204276192
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities462723191699
Accounts payable13887433
Accrued liabilities331915121264
Employee-related liabilities      2
Interest and dividends payable      0
Deferred revenue88
Debt 3    3
Derivative instruments and hedges, liabilities33     
Contract with customer, liability9
Other liabilities      0
Other undisclosed current liabilities4  233(2)
Total current liabilities:61413221201210
Noncurrent Liabilities
Long-term debt and lease obligation20826     
Long-term debt, excluding current maturities181      
Operating lease, liability2726
Liabilities, other than long-term debt7748496655
Deferred revenue and credits3444
Deferred revenue7748
Contract with customer, liability43
Deferred rent credit  3
Other liabilities    0  
Derivative instruments and hedges, liabilities  33212
Other undisclosed noncurrent liabilities    251
Total noncurrent liabilities:285744968116
Total liabilities:3461158127272316
Stockholders' equity
Stockholders' equity attributable to parent374225146269177253176
Common stock0000000
Additional paid in capital1,5011,070830811599586435
Accumulated other comprehensive income (loss) 0(0) (0)(0) 
Accumulated deficit(1,126)(844)(685)(542)(422)(332)(259)
Total stockholders' equity:374225146269177253176
TOTAL LIABILITIES AND EQUITY:720340226296204276192

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues15040000
Revenue, net   0
Cost of revenue(6)  (0)(0)(0)(0)
Cost of goods and services sold(6)      
Financial services costs(0)(0)(0)(0)
Gross profit:904(0)(0)(0)0
Operating expenses(288)(165)(146)(121)(89)(73)(52)
Other undisclosed operating income6  0000
Operating loss:(273)(164)(143)(120)(88)(72)(52)
Nonoperating income (expense)45311(0)(0)
Investment income, nonoperating4641100
Other nonoperating expense(1)(0)(1)(1)(1)(0)(0)
Interest and debt expense(15) (0)(0)(1)(1)(19)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (1)   
Loss from continuing operations before income taxes:(285)(159)(139)(121)(89)(74)(71)
Income tax expense (benefit)3 (3)    
Net loss:(282)(159)(142)(121)(89)(74)(71)
Other undisclosed net income (loss) attributable to parent(0)(0)(0) (1)08
Net loss available to common stockholders, diluted:(282)(159)(143)(121)(89)(73)(63)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(282)(159)(142)(121)(89)(74)(71)
Comprehensive loss:(282)(159)(142)(121)(89)(74)(71)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)(0)0(1)0 
Comprehensive loss, net of tax, attributable to parent:(282)(159)(143)(121)(89)(74)(71)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: